Edge Capital Group LLC Has $16.41 Million Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Edge Capital Group LLC raised its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 3.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 51,067 shares of the company’s stock after acquiring an additional 1,740 shares during the quarter. Edge Capital Group LLC’s holdings in HCA Healthcare were worth $16,407,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Vanguard Group Inc. raised its stake in shares of HCA Healthcare by 0.4% during the 1st quarter. Vanguard Group Inc. now owns 16,989,683 shares of the company’s stock worth $5,666,569,000 after purchasing an additional 60,304 shares in the last quarter. Sanders Capital LLC increased its stake in shares of HCA Healthcare by 4.2% during the 4th quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock worth $3,086,836,000 after purchasing an additional 456,738 shares during the last quarter. Wellington Management Group LLP lifted its stake in shares of HCA Healthcare by 1.7% in the 4th quarter. Wellington Management Group LLP now owns 10,186,129 shares of the company’s stock valued at $2,757,181,000 after purchasing an additional 170,560 shares during the last quarter. Royal Bank of Canada increased its position in HCA Healthcare by 35.7% during the fourth quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock worth $1,219,121,000 after buying an additional 1,183,890 shares during the last quarter. Finally, Capital World Investors lifted its position in shares of HCA Healthcare by 57.5% in the first quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock worth $931,342,000 after buying an additional 1,019,750 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

HCA has been the subject of several analyst reports. Barclays boosted their target price on HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a report on Wednesday, July 24th. UBS Group lifted their target price on shares of HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a report on Wednesday, August 14th. Baird R W raised HCA Healthcare to a “strong-buy” rating in a research report on Thursday, May 30th. Wolfe Research raised HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Finally, StockNews.com upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Monday, July 1st. Five investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have assigned a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $359.89.

Insider Buying and Selling

In other news, SVP Kathryn A. Torres sold 1,857 shares of the business’s stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the sale, the senior vice president now owns 17,755 shares in the company, valued at $6,303,912.75. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the business’s stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the sale, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The disclosure for this sale can be found here. Insiders sold 17,202 shares of company stock worth $6,407,273 in the last quarter. Insiders own 1.60% of the company’s stock.

HCA Healthcare Trading Up 0.3 %

Shares of HCA Healthcare stock opened at $404.66 on Friday. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. The stock has a market capitalization of $105.99 billion, a P/E ratio of 20.17, a price-to-earnings-growth ratio of 1.46 and a beta of 1.67. HCA Healthcare, Inc. has a 12-month low of $215.96 and a 12-month high of $405.70. The company has a 50-day simple moving average of $370.57 and a 200 day simple moving average of $340.65.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. The firm had revenue of $17.49 billion during the quarter, compared to analysts’ expectations of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The business’s revenue was up 10.3% on a year-over-year basis. During the same period last year, the firm posted $4.29 EPS. Research analysts expect that HCA Healthcare, Inc. will post 22.46 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be paid a dividend of $0.66 per share. The ex-dividend date of this dividend is Monday, September 16th. This represents a $2.64 annualized dividend and a dividend yield of 0.65%. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.16%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.